Embrace is an AI-enabled medical device from Empatica Srl, listed by FDA (510(k), K181861) with a decision date of 2018-12-20. Review panel: Neurology.
| FDA submission number | K181861 |
|---|---|
| Pathway | 510(k) |
| Company | Empatica Srl |
| Review panel (specialty) | Neurology |
| FDA decision date | 2018-12-20 |
| Decision | Substantially Equivalent |
| Product code | POS |
| Classification | Physiological Signal Based Seizure Monitoring System |
| Device class | 2 |
| Regulation number | 882.1580 |
| Review time (calendar days) | 161 |
| Applicant country | IT |
Official FDA database record · FDA AI-enabled device list
More devices from Empatica Srl · All Neurology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.